End-of-day quote
Shenzhen S.E.
18:00:00 2024-06-27 EDT
|
5-day change
|
1st Jan Change
|
20.38
CNY
|
+2.72%
|
|
-5.30%
|
-1.78%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,266
|
1,898
|
2,235
|
2,133
|
1,472
|
2,222
|
Enterprise Value (EV)
1 |
2,143
|
1,807
|
2,215
|
2,249
|
1,666
|
2,521
|
P/E ratio
|
94.3
x
|
64.8
x
|
37
x
|
67.8
x
|
26.9
x
|
30.7
x
|
Yield
|
0.42%
|
0.67%
|
0.84%
|
1%
|
1.09%
|
1.2%
|
Capitalization / Revenue
|
2.23
x
|
1.99
x
|
1.96
x
|
1.29
x
|
0.86
x
|
1.22
x
|
EV / Revenue
|
2.1
x
|
1.9
x
|
1.95
x
|
1.36
x
|
0.98
x
|
1.38
x
|
EV / EBITDA
|
69.1
x
|
42.4
x
|
23.4
x
|
36.8
x
|
17.8
x
|
18.4
x
|
EV / FCF
|
-41.8
x
|
-213
x
|
45.1
x
|
-20.9
x
|
-39
x
|
-27.9
x
|
FCF Yield
|
-2.4%
|
-0.47%
|
2.21%
|
-4.77%
|
-2.57%
|
-3.58%
|
Price to Book
|
3.33
x
|
2.72
x
|
3.1
x
|
2.89
x
|
1.9
x
|
2.54
x
|
Nbr of stocks (in thousands)
|
108,800
|
108,800
|
106,505
|
106,433
|
106,620
|
107,103
|
Reference price
2 |
20.82
|
17.45
|
20.99
|
20.04
|
13.81
|
20.75
|
Announcement Date
|
19-04-25
|
20-04-19
|
21-04-25
|
22-04-21
|
23-04-21
|
24-04-19
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,018
|
953.2
|
1,139
|
1,659
|
1,708
|
1,829
|
EBITDA
1 |
31.01
|
42.57
|
94.55
|
61.07
|
93.5
|
136.8
|
EBIT
1 |
11.66
|
22.51
|
73.28
|
30.09
|
53.46
|
89.21
|
Operating Margin
|
1.14%
|
2.36%
|
6.44%
|
1.81%
|
3.13%
|
4.88%
|
Earnings before Tax (EBT)
1 |
25.29
|
29.87
|
68.94
|
29.9
|
54.1
|
74.06
|
Net income
1 |
23.03
|
29.27
|
61.17
|
31.78
|
55.4
|
72.55
|
Net margin
|
2.26%
|
3.07%
|
5.37%
|
1.92%
|
3.24%
|
3.97%
|
EPS
2 |
0.2208
|
0.2691
|
0.5680
|
0.2956
|
0.5139
|
0.6759
|
Free Cash Flow
1 |
-51.32
|
-8.491
|
49.06
|
-107.4
|
-42.78
|
-90.25
|
FCF margin
|
-5.04%
|
-0.89%
|
4.31%
|
-6.47%
|
-2.51%
|
-4.93%
|
FCF Conversion (EBITDA)
|
-
|
-
|
51.89%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
80.21%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0882
|
0.1176
|
0.1765
|
0.2000
|
0.1500
|
0.2500
|
Announcement Date
|
19-04-25
|
20-04-19
|
21-04-25
|
22-04-21
|
23-04-21
|
24-04-19
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
116
|
194
|
299
|
Net Cash position
1 |
123
|
91
|
20.4
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
1.902
x
|
2.075
x
|
2.185
x
|
Free Cash Flow
1 |
-51.3
|
-8.49
|
49.1
|
-107
|
-42.8
|
-90.2
|
ROE (net income / shareholders' equity)
|
4.06%
|
4.23%
|
8.58%
|
4.11%
|
6.97%
|
8.15%
|
ROA (Net income/ Total Assets)
|
0.8%
|
1.39%
|
3.83%
|
1.31%
|
2.13%
|
3.02%
|
Assets
1 |
2,862
|
2,099
|
1,598
|
2,422
|
2,605
|
2,405
|
Book Value Per Share
2 |
6.250
|
6.420
|
6.780
|
6.940
|
7.270
|
8.160
|
Cash Flow per Share
2 |
2.330
|
1.100
|
1.170
|
1.100
|
0.8600
|
0.8200
|
Capex
1 |
17.5
|
45.6
|
48.7
|
38.7
|
75.4
|
84.2
|
Capex / Sales
|
1.72%
|
4.79%
|
4.27%
|
2.33%
|
4.41%
|
4.61%
|
Announcement Date
|
19-04-25
|
20-04-19
|
21-04-25
|
22-04-21
|
23-04-21
|
24-04-19
|
|
1st Jan change
|
Capi.
|
---|
| -1.78% | 298M | | +19.99% | 67.97B | | -6.03% | 45.92B | | +22.27% | 43.74B | | +33.20% | 28.16B | | +8.15% | 19.17B | | +14.71% | 17.12B | | -13.18% | 14.73B | | -27.99% | 14.52B | | -32.33% | 11.64B |
Other Specialty Chemicals
|